Lilly accused at trial of hiding Cymbalta ‘brain zap’ risk
The drugmaker faces as many as 5,000 cases claiming it downplayed Cymbalta’s withdrawal risks, which allegedly include electrical-shock sensations, vomiting and insomnia.
Bloomberg News
Articles
Indiana, other coal states vow not to cooperate with emission regs
Mike Pence joined a chorus of other Republican governors in vowing full-scale resistance, including outright defiance, of President Obama’s curbs on greenhouse-gas emissions from power plants.
Evansville’s Berry Plastics diversifies with $2.45B buy
Berry's purchase of Avintiv is the latest in a string of deals in the fast-consolidating packaging industry.
Health spending to gobble up more of U.S. economy
Payments for hospitals, doctors, drugs and insurance will rise by about 5.8 percent a year through 2024—1.1 percentage points faster than overall economic growth, actuaries at the Centers for Medicare and Medicaid Services said Tuesday in an annual study.
Global Logistic moves past Duke with $4.55B acquisition
Global Logistic Properties Ltd. agreed to buy more than 200 warehouses from Industrial Income Trust Inc. in a deal that will make it the second-largest owner of U.S. industrial real estate, ahead of Indianapolis-based Duke Realty Corp.
UPDATE: Brady ban upheld as NFL seeks order affirming decision
The National Football League is poised for a legal battle with one of its most popular stars after Commissioner Roger Goodell upheld the four-game suspension of New England Patriots quarterback Tom Brady for conduct detrimental to the integrity of the league.
Anthem gets $26.5B funding commitment for Cigna takeover
Anthem Inc.’s bid to become the largest health insurer in history is setting up one of the biggest debt offerings backing a takeover.
Clock ticking for decision on landmark insider-trading ruling
Time is running out for the United States to ask the Supreme Court to review a ruling that could lay the framework for how insider trading will be prosecuted for years to come.
Simon sees jump in cash flow, sunny skies ahead
Simon Property Group Inc., the largest U.S. mall owner, on Friday reported a 22-percent jump in second-quarter funds from operations and increased its full-year forecast as rising employment helps lure shoppers.
Taxpayers could lose billions as U.S. students escape loans
The unwinding of for-profit education companies could allow tens of thousands of students to walk away from their federal loan obligations.
Owner of 3 Indiana casinos sells real estate in $4.7B deal
The deal will create a combined real estate investment trust that will own 35 casino and hotel facilities in 14 states, including three in Indiana.
NCAA seeks to halt looming rule allowing colleges to pay athletes
The National Collegiate Athletic Association has asked an appeals court to block a ruling that requires the organization to allow its member schools to pay student-athletes at least $5,000 a year starting Aug. 1.
Lilly partner Immunocore raises record $320 million
Immunocore Ltd., which this week achieved the biggest private fundraising by a European biotechnology firm in 10 years, plans to accelerate development of its cancer therapy using the money and seek expedited approval.
NCAA must pay $46 million in legal fees in O’Bannon lawsuit
Judge Nathanael Cousins cited the “Game of Thrones” series in awarding the fees and costs to the attorneys who represented Ed O’Bannon, the former UCLA basketball player who challenged the NCAA’s rule restricting athlete compensation in a 2009 lawsuit.
Subway planned to rebrand Fogle as family man before raid by FBI
Before federal investigators raided the Zionsville home of Subway spokesperson Jared Fogle on Tuesday, the company was in the midst of rebranding him to revive stagnant sales.
New York Stock exchange shutdown lasts three-plus hours
The New York Stock Exchange halted trading for 3-1/2 hours Wednesday because of a computer malfunction, forcing traders to route orders elsewhere in a drama that also highlighted the resilience of U.S. market structure.
New York Stock Exchange suspends trading in all securities
Equity trading was halted Wednesday at the New York Stock Exchange as the biggest American share venue addressed a computer malfunction and canceled open orders.
Lilly, partner sue Lupin over generic testosterone
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
Clot risk in Lilly lung-cancer drug raises FDA concerns
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Aetna-Humana deal could push Cigna to take Anthem offer
With Aetna Inc. and Humana Inc. agreeing to a $37 billion merger, pressure is mounting on the other major health insurers, including Cigna Corp. and Anthem Inc., to make their own deals.